Flagship Ventures Fund IV General Partner LLC 13D and 13G filings for Moderna, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 3:00 pm Sale | 2021-12-31 | 13G | Moderna, Inc. MRNA | Flagship Ventures Fund IV General Partner LLC | 20,008,540 4.900% | -13,134,971 (-39.63%) | Filing |
| 2021-02-16 5:02 pm Sale | 2020-12-31 | 13G | Moderna, Inc. MRNA | Flagship Ventures Fund IV General Partner LLC | 33,143,511 8.400% | -17,865,181 (-35.02%) | Filing |
| 2020-02-13 4:15 pm Sale | 2019-12-31 | 13G | Moderna, Inc. MRNA | Flagship Ventures Fund IV General Partner LLC | 51,008,692 15.310% | -7,914,311 (-13.43%) | Filing |